Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2026-02-07 @ 4:18 PM
Study NCT ID:
NCT00710892
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-11
First Post:
2008-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
Sponsor:
Baylor College of Medicine
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | suicide gene-modified allodepleted donor lymphocytes | View |
| None | given to recipients of haploidentical stem cell transplants | View |
| None | Stage III | View |
| None | Stage IV | View |
| None | Myelodysplastic syndrome | View |
| None | AML after first relapse | View |
| None | primary refractory disease | View |
| None | CML | View |
| None | Hemophagocytic lymphohistiocytosis (HLH) | View |
| None | familial hemophagocytic lymphohistiocytosis (FLH) | View |
| None | viral-associated hemophagocytic syndrome (VAHS) | View |
| None | Severe chronic active Epstein Barr virus infection (SCAEBV) | View |
| None | T or NK cell malignancy | View |
| None | X-linked lymphoproliferative disease (XLP) | View |